James Carmichael
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
Papers in
-
- Protein Degradation and Inhibitors 3
- Ubiquitin and proteasome pathways 2
- Ion channel regulation and function 1
-
- Multiple Myeloma Research and Treatments 3
- Acute Myeloid Leukemia Research 1
- Co-authors
- Brian E. Cathers (3 shared papers)Chin-Chun Lu (2 shared papers)Philip P. Chamberlain (2 shared papers)Gang Lu (2 shared papers)Mary E. Matyskiela (2 shared papers)Weihong Zhang (1 shared paper)Matthew Hickman (1 shared paper)Barbra Pagarigan (1 shared paper)
- Journals
- Blood (2 papers)Journal of Cardiovascular Pharmacology and Therapeutics (1 paper)Journal of Medicinal Chemistry (1 paper)Journal of Clinical Oncology (1 paper)eLife (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
James Carmichael
10 papers receiving 327 citations
Peers
Comparison fields: 5 of 49
- Hematology 132
- Molecular Biology 272
- Oncology 99
- Immunology 16
- Orthopedics and Sports Medicine 6
Countries citing papers authored by James Carmichael
This map shows the geographic impact of James Carmichael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Carmichael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Carmichael more than expected).
Fields of papers citing papers by James Carmichael
This network shows the impact of papers produced by James Carmichael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Carmichael. The network helps show where James Carmichael may publish in the future.
Co-authors
The 25 scholars most cited alongside James Carmichael, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 212 | |
| 2 | 2018 | 56 | |
| 3 | 1996 | 24 | |
| 4 | 2024 | 21 | |
| 5 | 2019 | 13 | |
| 6 | The effect of cranklength on oxygen consumption when cycling at a constant work rate | 1983 | 4 |
| 7 | 2013 | 4 | |
| 8 | 1982 | 4 | |
| 9 | HIV/AIDS primary care handbook | 1995 | 2 |
| 10 | 2018 | 1 | |
| 11 | 2023 | 0 | |
| 12 | 2020 | 0 |
About James Carmichael
James Carmichael is a scholar working on Molecular Biology, Hematology, Genetics, Cardiology and Cardiovascular Medicine and Oncology, having authored 12 papers that have together received 341 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (3 papers), Multiple Myeloma Research and Treatments (3 papers), Cardiovascular and exercise physiology (2 papers), Ubiquitin and proteasome pathways (2 papers), Cardiac pacing and defibrillation studies (2 papers), Acute Myeloid Leukemia Research (1 paper), Cardiac electrophysiology and arrhythmias (1 paper) and Ion channel regulation and function (1 paper). The work is most often cited by research in Hematology (132 citations), Molecular Biology (272 citations), Oncology (99 citations), Immunology (16 citations) and Orthopedics and Sports Medicine (6 citations). James Carmichael has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Brian E. Cathers, Chin-Chun Lu, Philip P. Chamberlain, Gang Lu, Mary E. Matyskiela, Weihong Zhang, Matthew Hickman, Barbra Pagarigan, Peter Schäfer and Laurie A. LeBrun. Their work appears in journals such as Blood, Journal of Cardiovascular Pharmacology and Therapeutics, Journal of Medicinal Chemistry, Journal of Clinical Oncology and eLife.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.